Pharmacokinetics of Low and Maintenance Dose Valganciclovir in Kidney Transplant Recipients

Valganciclovir is commonly used for cytomegalovirus (CMV) prophylaxis in renal transplant patients. A fixed dose of 900 mg daily is typically recommended, however, there has never been a formal pharmacokinetic study comparing various doses in renal transplant patients. We therefore compared the phar...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Chamberlain, C. E., Penzak, S. R., Alfaro, R. M., Wesley, R., Daniels, C. E., Hale, D., Kirk, A. D., Mannon, R. B.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2008
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2532821/
https://ncbi.nlm.nih.gov/pubmed/18444933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2008.02220.x
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items